Screening of optimal candidates for postoperative radiotherapy among patients with resectable thymic tumors: a multicenter retrospective study
PORT provides significant survival benefits in patients with Masaoka-Koga stage IIB and III/IVA thymic tumors, aggressive histological subtypes, and thymic carcinoma.
Authors
- Shang-Qun Liu
- Qi Chen (ORCID: https://orcid.org/0009-0001-2316-4521)
- Hui Liu (ORCID: https://orcid.org/0000-0002-3741-5686)
- Jian Li (ORCID: https://orcid.org/0000-0002-4549-0694)
- Lian Duan (ORCID: https://orcid.org/0000-0002-2578-2876)
- Jianyu Xu (ORCID: https://orcid.org/0000-0002-0870-7671)
- Shilong Liu (ORCID: https://orcid.org/0009-0004-6740-5210)
- Songliu Hu
- Jianli Ma (ORCID: https://orcid.org/0009-0008-0362-7075)
Institutions
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Lung Cancer
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1016/j.lungcan.2025.108542
- Citations
- 1
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 1.39